Ketas (Ibudilast) 500 Capsules: A Strategic Supply for Sustained Neuroprotection and Asthma Control

When managing chronic, slowly progressive conditions — such as bronchial asthma, multiple sclerosis, or amyotrophic lateral sclerosis (ALS) — the continuity of the treatment course becomes paramount. Ketas (Ibudilast) in the economical 500-capsule pack (10 mg each), manufactured by Japan’s Kyorin Pharmaceutical, is a solution designed for long-haul, uninterrupted therapy. This bulk presentation spares the patient from frequent pharmacy visits and helps lock in a stable treatment routine.

🔬 Molecular Portrait and Pharmacodynamics

Ibudilast is a multifunctional compound with established anti-inflammatory and neuroprotective properties. Its biochemical action rests on the inhibition of phosphodiesterases (PDEs) — the enzymes tasked with degrading the intracellular second messengers cAMP and cGMP.

The drug exhibits the highest affinity for the PDE4 isoform, which is densely expressed in immune cells, bronchial smooth muscle, and microglia (the resident immune cells of the central nervous system). By blocking PDE4, ibudilast activates a cascade of protective effects:

• In the Lungs: Relaxes airway smooth muscle, suppresses bronchial hyperreactivity, and quells local inflammation.
• In the Brain: Restrains pathological microglial activation, preventing the excessive production of pro-inflammatory cytokines that are toxic to neurons.
• In the Vascular System: Helps improve cerebral blood flow, alleviating symptoms such as post-stroke dizziness.

📋 Spheres of Clinical Application

Accumulated clinical evidence delineates several key therapeutic niches for this agent:

1. Neurodegenerative Pathology:
   • Multiple Sclerosis: Slowing the rate of whole-brain atrophy and the progression of neurological disability.
   • Amyotrophic Lateral Sclerosis (ALS): In Japan, ibudilast is approved under the Radicavit brand to reduce excitotoxic motor neuron injury driven by excess glutamate, thereby helping to extend the window of preserved motor independence.
2. Cerebrovascular Pathology: Mitigating the subjective and objective manifestations of chronic cerebral circulatory insufficiency, particularly dizziness stemming from a prior cerebral infarction.
3. Bronchopulmonary Pathology: Baseline anti-inflammatory treatment for bronchial asthma, aimed at decreasing exacerbation frequency and the severity of bronchospasm.

💊 Dosage Form and Administration Regimen

The product is supplied as hard gelatin capsules (white body and cap). A single pack contains 500 units, which, at a typical daily dose of 20–30 mg (2–3 capsules), provides between 5 and 8 months of uninterrupted treatment.

Standard intake protocols (always subject to physician-led individualization):

• For Bronchial Asthma: One capsule (10 mg) twice daily.
• For Cerebrovascular Disorders: One capsule (10 mg) three times daily.
• For ALS and Multiple Sclerosis: The regimen is tailored strictly on a case-by-case basis by the treating neurologist, accounting for tolerability and clinical response.

Capsules are taken orally with ample water. Food timing is not critical, though maintaining even intervals between doses is encouraged to sustain stable plasma concentrations.

⚠️ Cautions and Safety Profile

Before initiating therapy, the patient must inform the physician of the following:

• Any history of allergic reactions to medications.
• Recent intracranial hemorrhage (constitutes an absolute contraindication).
• Current or planned pregnancy, or active breastfeeding.
• Concurrent use of any other drugs (including over-the-counter and dietary supplements) due to the risk of drug-drug interactions.

Should adverse effects occur, they are most often limited to mild gastrointestinal symptoms (diminished appetite, slight nausea) or cutaneous hypersensitivity manifestations (rash, itching). However, there are red-flag signals demanding immediate drug discontinuation and medical contact: the emergence of a bleeding tendency, unexplained bruising, or yellowing of the skin and sclera.

📦 Storage and Responsible Use

The bulk pack size demands disciplined adherence to storage rules: capsules must be kept in a cool, dry place, protected from direct UV light, and well out of children’s reach. Any unused remnants must be properly disposed of — do not stockpile leftovers.

This material is provided for informational and educational purposes only. The prescription of ibudilast is the exclusive prerogative of a qualified physician. Self-directed treatment of chronic neurodegenerative and bronchopulmonary diseases is inadmissible and may carry serious health consequences.

📦Find out about the delivery to your country on WhatsApp